Evoke Pharma Free Cash Flow 2012-2023 | EVOK

Evoke Pharma free cash flow from 2012 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
Evoke Pharma Annual Free Cash Flow
2023 -4.99
2022 -6.60
2021 -12.35
2020 -6.63
2019 -5.76
2018 -6.98
2017 -8.72
2016 -8.71
2015 -10.50
2014 -11.50
2013 -3.04
2012 -1.75
2011 -2.89
Evoke Pharma Quarterly Free Cash Flow
2023-12-31 -4.99
2023-09-30 -3.88
2023-06-30 -2.84
2023-03-31 -1.63
2022-12-31 -6.60
2022-09-30 -4.09
2022-06-30 -2.99
2022-03-31 -1.62
2021-12-31 -12.35
2021-09-30 -10.36
2021-06-30 -4.46
2021-03-31 -2.95
2020-12-31 -6.63
2020-09-30 -4.92
2020-06-30 -3.11
2020-03-31 -1.55
2019-12-31 -5.76
2019-09-30 -4.61
2019-06-30 -3.56
2019-03-31 -1.93
2018-12-31 -6.98
2018-09-30 -5.73
2018-06-30 -4.58
2018-03-31 -2.82
2017-12-31 -8.72
2017-09-30 -5.98
2017-06-30 -3.78
2017-03-31 -1.69
2016-12-31 -8.71
2016-09-30 -7.34
2016-06-30 -4.92
2016-03-31 -2.69
2015-12-31 -10.50
2015-09-30 -8.04
2015-06-30 -5.54
2015-03-31 -3.00
2014-12-31 -11.50
2014-09-30 -8.98
2014-06-30 -5.07
2014-03-31 -2.00
2013-12-31 -3.04
2013-09-30 -1.15
2013-06-30 -0.88
2013-03-31 -0.45
2012-12-31
2012-09-30 -1.10
2012-06-30 -0.80
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.004B $0.005B
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.855B 5.36
Dr Reddy's Laboratories (RDY) India $12.352B 19.53
Aspen Pharmacare (APNHY) South Africa $5.038B 0.00
BridgeBio Pharma (BBIO) United States $4.278B 0.00
Bausch Health Cos (BHC) Canada $3.150B 2.46
Amphastar Pharmaceuticals (AMPH) United States $1.995B 13.66
Supernus Pharmaceuticals (SUPN) United States $1.604B 0.00
Taysha Gene Therapies (TSHA) United States $0.430B 0.00
Generation Bio (GBIO) United States $0.200B 0.00
Assembly Biosciences (ASMB) United States $0.073B 0.00
Personalis (PSNL) United States $0.063B 0.00
Acasti Pharma (ACST) Canada $0.028B 0.00
Sol-Gel Technologies (SLGL) Israel $0.024B 0.00
Teligent (TLGT) United States $0.000B 0.00